SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

Dr. Omar Tupayachi - 24 June, 2026 0

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Dr. Juan Manuel Pérez - 23 June, 2026 0

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

Inflammation after TAVI: An Emerging Therapeutic Target?

Dr. Juan Manuel Pérez - 22 June, 2026 0

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso - Políticas de privacidad.

Tag: HERA-TAVI

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

Últimas Noticias

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Inflammation after TAVI: An Emerging Therapeutic Target?

Noticias Institucionales

Fellow’s Corner – Case 2: Acute Myocardial Infarction Due to Simultaneous Occlusion of Two Coronary Arteries

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

Accesos